| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000032478 |
| Receipt No. | R000037033 |
| Scientific Title | Right ventricular pacing during Cryoballoon ablation for atrial fibrillation |
| Date of disclosure of the study information | 2018/06/01 |
| Last modified on | 2021/11/09 (Ver. 4) |
| Basic information | ||
| Public title | Right ventricular pacing during Cryoballoon ablation for atrial fibrillation | |
| Acronym | RVP study | |
| Scientific Title | Right ventricular pacing during Cryoballoon ablation for atrial fibrillation | |
| Scientific Title:Acronym | RVP study | |
| Region |
|
|
| Condition | ||
| Condition | Non-valvular atrial fibrillation | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Cryobaloon ablation for patients with atrial fibrillation is widely practiced worldwide including Japan as a safe and effective treatment. It has been reported that the nadir temperature of the cryoballoon is a predictor of myocardial injury during pulmonary vein isolation. And blood flow reduction in the left atrium by high frequency right ventricular pacing has been reported to contribute significantly reduction of the balloon temperature.
Right ventricular pacing is a procedure performed from an electrode catheter inserted in the right ventricle and has also been performed in daily cardiac electrophysiological examination, and its safety has been established. We randomize the patients who underwent cryoballoon ablation in our institution to two groups whether or not high frequency right ventricular pacing is performed during cryoballoon freezing and observe prospectively the effect of myocardial injury and atrial fibrillation recurrence in the acute and chronic period. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Myocardial injury during catheter ablation
Recurrence of atrial fibrillation |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Pulmonary vein isolation is performed normally as a cryoballoon. | |
| Interventions/Control_2 | High frequency right ventricular pacing is performed with an electrode catheter inserted from the femoral vein during cryoballoon freezing. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Patients who underwent cryoballoon ablation for atrial fibrillation at our hospital
2. Patients who is 20 years of age or older 3. Patietns who obtained written consent. |
|||
| Key exclusion criteria | 1. Patients who are suffering from cancer and have not received notification (at the time of consent acquisition)
2. Patients who have low left ventricular ejection fraction (less than 30%) or severe aortic valve stenosis 3. Patients who have coronary artery stenosis by preoperative evaluation 4. Patients who have been judged as the inappropriate subject of this research by the research director or assigned researcher |
|||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Japan Red Cross Yokohama City Bay Hospital | ||||||
| Division name | Heart Center | ||||||
| Zip code | |||||||
| Address | 3-12-1 Shinyamashita Naka-ward Yokohama Kanagawa 231-0801, Japan | ||||||
| TEL | 045-628-6100 | ||||||
| takhighstepping326@yahoo.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Japan Red Cross Yokohama City Bay Hospital | ||||||
| Division name | Heart Center | ||||||
| Zip code | |||||||
| Address | 3-12-1 Shinyamashita Naka-ward Yokohama Kanagawa 231-0801, Japan | ||||||
| TEL | 045-628-6100 | ||||||
| Homepage URL | |||||||
| takhighstepping326@yahoo.co.jp | |||||||
| Sponsor | |
| Institute | Japan Red Cross Yokohama City Bay Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000037033 |